Skip to content
In Stock Clonidine
Hypertension

Clonidine

Clonidine hydrochloride is a centrally acting alpha-2 adrenergic agonist prescribed mainly for hypertension. The regimen for the selected tablet strength should be confirmed with a healthcare…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Clonidine
Select pack Package Per unit Price
$ 13.88 $ 138.84
$ 7.74 $ 277.68 $ 154.86 Save 44%
$ 5.76 $ 416.52 $ 172.66 Save 59%
$ 2.29 $ 1,249.56 $ 206.48 Save 83%
$ 1.87 $ 1,666.08 $ 224.28 Save 87%
$ 1.34 $ 2,499.12 $ 242.08 Save 90%
$ 1.02 $ 3,748.68 $ 275.90 Save 93%
Best value $ 0.91 $ 4,998.24 $ 327.52 Save 93%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Clonidine hydrochloride is a centrally acting alpha-2 adrenergic agonist prescribed mainly for hypertension. The regimen for the selected tablet strength should be confirmed with a healthcare professional, and the medicine can lower blood pressure by reducing excessive sympathetic nerve activity.

Product information

Clonidine hydrochloride, a centrally acting alpha-2 adrenergic agonist, is the active substance in Clonidine tablets. It is prescribed mainly for hypertension and can lower blood pressure by reducing excessive sympathetic nerve activity.

Ingredients

The active substance is clonidine hydrochloride, a centrally acting alpha-2 adrenergic agonist. It is used mainly for hypertension and can lower blood pressure by reducing excessive sympathetic nerve activity. The exact regimen for the selected tablet strength must be confirmed with a healthcare professional before treatment begins.

Therapeutic indications

Clonidine is primarily prescribed for hypertension. By reducing sympathetic outflow, it can lower blood pressure when increased autonomic activity contributes to the patient’s condition. The US FDA prescribing information for clonidine hydrochloride tablets describes hypertension as the established indication for oral treatment [1]. Individual response can vary even when the indication is appropriate. Blood-pressure monitoring remains necessary after treatment begins.

Clinicians may also use clonidine in selected situations outside its primary approved indication. These uses depend on the patient’s symptoms, medical history, and the prescriber’s assessment:

  • Attention deficit hyperactivity disorder, especially when impulsivity, hyperactivity, sleep difficulty, or tics are relevant
  • Tic disorders, including Tourette syndrome
  • Menopausal vasomotor symptoms such as hot flushes
  • Autonomic symptoms during opioid or alcohol withdrawal support
  • Selected pain-management situations under specialist supervision

Off-label use means that a prescriber uses an established medicine for a clinical purpose that may differ from the main regulatory indication. It does not mean that the medicine has a different mechanism. The expected benefit must be balanced against sedation, low blood pressure, slow heart rate, and the risk of rebound hypertension after sudden withdrawal.

Clinical use depends on the objective:

  • For hypertension, the target is sustained reduction of blood pressure.
  • For ADHD or tics, the target may include reduced hyperactivity, impulsivity, or motor symptoms.
  • For hot flushes, the aim is fewer or less intense vasomotor episodes.
  • During withdrawal support, clonidine can reduce some autonomic symptoms, but it does not replace structured treatment for dependence.
Clonidine can reduce physical symptoms linked to autonomic overactivity, but it does not remove the underlying cause of withdrawal or dependence. A sudden improvement in sweating or agitation should not be used as a reason to stop structured treatment.

Directions for use

The regimen for the selected tablet strength must be confirmed with a healthcare professional before starting. Clonidine dosing is individualised because the appropriate amount depends on blood pressure, heart rate, kidney function, age, other medicines, and the treatment goal.

Tablet administration

  • Take the prescribed dose at the prescribed times.
  • Swallow the tablet with water.
  • Take doses consistently at the same times each day.
  • Avoid changing the dose because of one high or low blood-pressure reading.
  • Do not stop treatment suddenly.
  • If a dose is missed, take it when remembered unless the next scheduled dose is close; do not double the next dose.

Oral solutions and injectable clonidine preparations exist in clinical practice, but they are not interchangeable with tablets on a milligram-for-milligram basis without a prescriber’s instruction. Injectable preparations require clinical supervision. A tablet regimen should not be converted to another formulation independently.

Titration means adjusting the dose gradually. This approach helps clinicians balance blood-pressure reduction against dizziness, sedation, bradycardia, and low blood pressure on standing. The need for gradual reduction is just as important as gradual dose adjustment upward.

Abrupt withdrawal can produce rebound hypertension, marked nervousness, headache, tremor, sweating, rapid heartbeat, or chest discomfort. The FDA prescribing information warns that withdrawal reactions may be more severe in patients receiving higher doses or concurrent beta-blocker therapy [2].

Keep a simple record of morning and evening blood-pressure readings during dose changes. Record dizziness, faintness, unusually slow pulse, and excessive sleepiness alongside the reading; those details help distinguish an insufficient dose from excessive treatment.

One practical issue is easy to miss: clonidine can lower blood pressure without removing every symptom of hypertension. A person may feel normal while pressure remains high, so treatment changes should not be based on symptoms alone.

When not to use it

Clonidine is not suitable when

  • There is a known allergy to clonidine or an excipient in the tablet.
  • The patient has significant bradycardia or clinically important conduction disease.
  • Blood pressure is already unusually low.
  • Previous clonidine treatment caused severe fainting, confusion, or a serious cardiovascular reaction.
  • The patient cannot follow a planned taper and is at high risk of abrupt interruption.
  • Severe kidney impairment requires closer dose selection and monitoring.

The main interaction risks involve additive effects on the cardiovascular system or central nervous system.

Interacting category Main concern Practical management
Beta-blockers Slow heart rate, excessive blood-pressure reduction, and difficult withdrawal reactions Use only with planned prescribing and monitored dose changes
Sedating medicines or alcohol Greater drowsiness, impaired concentration, dizziness, and falls Avoid combining casually; assess alertness before driving
Other blood-pressure medicines or central agents Additive hypotension, bradycardia, or sedation Blood pressure and pulse may need closer monitoring

Beta-blockers need special planning. Stopping clonidine while continuing a beta-blocker can increase the risk of marked rebound hypertension because the normal compensatory pathways are altered. Prescribers may adjust the sequence and timing of withdrawal according to the individual regimen.

The same caution applies to centrally acting agents that influence sympathetic tone, including methyldopa and moxonidine. Combining medicines from this group can intensify dizziness, tiredness, or slow heart rate.

When this is not for you

Clonidine is not suitable for everyone. Clonidine may not be for you if you have a known allergy, clinically significant bradycardia, very low blood pressure, or difficulty following a planned taper. Treatment requires extra caution when the patient has cardiovascular disease, low resting blood pressure, a slow pulse, kidney impairment, a history of fainting, or substantial sensitivity to sedating medicines.

A useful clinical detail concerns kidney function. Clonidine is cleared partly through the kidneys, so older adults and people with renal impairment may experience stronger or longer-lasting effects from a standard regimen.

Unwanted effects

Clonidine’s common adverse effects arise from central sympathetic suppression and reduced vascular tone. Drowsiness and dry mouth are among the effects patients report most often. Sedation may be strongest after starting treatment, taking a larger dose, or combining clonidine with another sedating substance.

Common or clinically recognised effects include:

  • Drowsiness or fatigue
  • Sedation and reduced concentration
  • Dry mouth
  • Dizziness, especially when standing
  • Constipation
  • Headache
  • Slow heart rate
  • Low blood pressure
  • Weakness
  • Sleep disturbance in some patients

Dry mouth can be uncomfortable at night. Small, regular sips of water and sugar-free gum may help, while excessive alcohol can worsen sedation and dehydration. Persistent constipation may respond to more fibre and fluid when those measures are suitable for the individual.

Orthostatic hypotension means a fall in blood pressure after standing. Rise slowly from bed or a chair, especially during the first week or after a dose increase. Sit down promptly if vision dims, balance worsens, or the legs feel weak.

Serious symptoms require urgent clinical assessment. These include fainting, severe weakness, an unusually slow heartbeat, confusion, breathing difficulty, chest pain, or a severe blood-pressure rise after missed doses or abrupt cessation.

A patient may feel sleepy without recognising impaired reaction speed. That distinction matters when driving, cycling in traffic, using tools, or supervising children. Clonidine can also make the effects of alcohol and other sedating medicines stronger.

The Therapeutic Goods Administration’s Australian medicine-safety information treats central sedation, cardiovascular effects, and withdrawal reactions as clinically relevant risks requiring individual assessment [3].

Mechanism of action

Clonidine belongs to the centrally acting alpha-2 adrenergic agonist class. It also binds to imidazoline receptors involved in autonomic regulation. Its main clinical role is blood-pressure control in hypertension.

After entering the central nervous system, clonidine stimulates presynaptic alpha-2 receptors in the brainstem. This reduces sympathetic outflow, meaning fewer nerve signals reach the heart and blood vessels. The resulting effects can include:

  • Lower peripheral vascular resistance
  • Slower heart rate
  • Reduced cardiac workload
  • Lower arterial blood pressure
  • Less release of norepinephrine from sympathetic nerve endings

Unlike a peripheral vasodilator, clonidine works primarily through central nervous system regulation. This mechanism explains both its blood-pressure action and its frequent sedating effects. The same central pathway can reduce alertness, especially during the first days of treatment or after a dose increase.

Receptor selectivity and central nervous system effects

Alpha-2 receptor stimulation decreases the release of norepinephrine, a neurotransmitter that normally increases vascular tone and cardiac activity. Imidazoline receptor binding may also contribute to autonomic effects, although the alpha-2 pathway is central to clonidine’s clinical action.

The blood-pressure response can develop alongside tiredness, slowed reactions, dry mouth, or dizziness when standing. These effects are pharmacological consequences of reduced sympathetic activity rather than signs that the medicine is acting only on the heart.

Common mistakes

Several avoidable habits can make clonidine appear ineffective or poorly tolerated:

  • Stopping suddenly after blood pressure improves
  • Taking an extra tablet after one high reading
  • Doubling the next dose after a missed dose
  • Standing quickly while already dizzy or dehydrated
  • Drinking alcohol during the first days of treatment
  • Driving before learning how strongly the medicine affects alertness
  • Failing to mention over-the-counter sedating products
  • Measuring blood pressure immediately after exercise or emotional stress and changing the dose independently
  • Switching between tablet and liquid preparations without a prescribed conversion
  • Treating reduced sweating or calmness as proof that withdrawal treatment is complete

One subtle mistake is taking clonidine inconsistently between morning and evening. Irregular timing can create alternating periods of sedation and reduced symptom control, especially when the medicine is being used for autonomic symptoms.

Another is confusing a low pulse with improved fitness. Clonidine can slow the heart through reduced sympathetic activity; a very slow pulse accompanied by faintness or weakness needs prompt assessment.

Comparison

Clonidine is one option among several approaches to blood-pressure treatment. The choice depends on the cause of hypertension, pregnancy status, kidney function, heart rate, coexisting conditions, and previous treatment response.

Treatment category Typical clinical role Main limitation
Clonidine Central reduction of sympathetic outflow; hypertension and selected specialist uses Sedation, dry mouth, bradycardia, and rebound hypertension after abrupt withdrawal
Methyldopa Centrally acting treatment, including selected hypertension-in-pregnancy pathways Sedation and other central effects; ongoing monitoring is required
Labetalol or nifedipine Common alternatives selected according to cardiovascular context and pregnancy-related assessment Each has different cardiovascular effects and contraindications

Moxonidine is another centrally acting option in some countries. Its receptor profile differs from clonidine, although both can reduce sympathetic activity. Switching between them requires a planned regimen rather than direct substitution.

Nifedipine acts mainly through calcium-channel blockade and peripheral vascular relaxation. Labetalol combines alpha- and beta-adrenergic blockade. Methyldopa reduces central sympathetic activity through a different biochemical pathway. These differences affect pulse rate, sedation, orthostatic symptoms, and pregnancy-related prescribing decisions.

The World Health Organization’s pharmacological classification places clonidine among centrally acting antihypertensive agents, while hypertension guidance from NICE places greater emphasis on treatment selection according to cardiovascular risk, age, comorbidities, and response [4]. A medicine with a different mechanism may be preferred when clonidine causes excessive sedation, when a stable once-daily strategy is needed, or when rebound risk would be difficult to manage.

What doctors say

In clinical practice, doctors usually set expectations before the first tablet: clonidine can lower blood pressure, but its tolerability often depends on careful titration. A patient who becomes sleepy, dizzy, or unusually slow in pulse may need a regimen review rather than simply abandoning treatment.

Physicians also pay attention to the pattern of readings. A single reading does not show whether treatment is controlling blood pressure throughout the day. Home readings taken at consistent times can reveal whether the effect is wearing off, becoming excessive, or varying with posture and activity.

Patients sometimes focus on dry mouth because it is noticeable, while the more serious issue is withdrawal. The prescriber’s plan should cover missed doses, planned dose reductions, and what to do if tablets cannot be taken because of vomiting or illness.

The EMA’s clinical pharmacology framework and Australian TGA medicine information support the same practical principle: central sympatholytic treatment needs individualised dosing, cardiovascular observation, and controlled withdrawal rather than abrupt interruption.

What customers often ask

What should be done after a missed Clonidine dose?

Take the missed tablet when remembered unless the next scheduled dose is close; never double the next dose. The FDA prescribing information for clonidine hydrochloride tablets, issued in 2016, warns that irregular interruption can contribute to withdrawal-related blood-pressure elevation. Contact the prescribing service promptly if several doses have been missed, especially when headache, tremor, palpitations, or a marked rise in blood pressure develops.

Which condition rules Clonidine out?

A known allergy, clinically significant bradycardia, or severe low blood pressure can rule clonidine out or require a different treatment plan. The TGA product information published in 2022 identifies cardiovascular effects and individual sensitivity as reasons for careful assessment. Kidney impairment does not automatically exclude treatment, but it can require closer monitoring and a more cautious regimen.

Which habits help or hinder the result?

Taking clonidine at consistent times, limiting alcohol, rising slowly, and keeping blood-pressure readings under similar conditions can support stable treatment. The WHO ATC/DDD Index from 2024 classifies clonidine as a centrally acting antihypertensive, while clinical response still depends on adherence and individual dose selection. Dehydration, missed doses, alcohol, and unsupervised dose changes can worsen dizziness or destabilise blood pressure.

Can Clonidine affect driving, concentration, or machinery work?

Yes. Drowsiness, slowed reactions, dizziness, and impaired concentration can occur, especially after starting treatment or increasing the dose. The EMA pharmacovigilance framework published in 2021 describes central nervous system effects as relevant considerations for medicines that influence alertness. Do not drive or operate machinery until the individual response is clear and alertness is reliable.

How long does one Clonidine dose keep working?

The duration varies with the regimen, kidney function, formulation, and individual response. The FDA prescribing information from 2016 describes clonidine as producing a sustained antihypertensive effect with regular oral dosing, but it does not make one fixed duration suitable for every patient. A dose should not be repeated early because the pressure has not changed yet; timing changes require a planned clinical review.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Abana

Active ingredient: Terminalia arjuna
60pills
From $ 158.42
bottles
3.5 (4)

Adalat

Active ingredient: Nifedipine
20mg 30mg 10mg
From $ 151.30
pills
4.1 (4)

Aldactone

Active ingredient: Spironolactone
100mg 25mg 50mg
From $ 156.64
pills
3.5 (5)

Azor

Active ingredient: Amlodipine, Olmesartan
20mg5mg 40mg5mg
From $ 213.60
pills
3.2 (3)

Clonidine Current

Active ingredient: Clonidine
0.1mg
From $ 138.84
pills
3.9 (5)

Propranolol

Active ingredient: Propranolol
40mg 80mg
From $ 140.62
pills
3.6 (5)

How the medicines for Hypertension compare

Sources

  1. FDA (2016). Catapres (clonidine hydrochloride) tablets prescribing information.
  2. FDA (2016). Clonidine hydrochloride tablets: prescribing information and withdrawal warnings.
  3. Therapeutic Goods Administration (2022). Product Information for clonidine hydrochloride tablets.
  4. World Health Organization (2024). ATC/DDD Index: clonidine.

How Buyers Rate Clonidine

Based on 5 reviews

Simon, 64 Verified
Rating: 3.5 out of 5

no city, took the 0.1 mg tablets after his blood pressure remained high despite lifestyle changes. He reported feeling sleepy for the first several days, then found the effect easier to manage when the timing was kept consistent. He had been surprised that stopping for two days caused a pounding headache and a sharp rise in his readings.

The first several days 28 Oct 2026
Liam, 36 Verified
Rating: 4 out of 5

no city, used clonidine under supervision for difficult evening restlessness and high sympathetic symptoms. He noticed a dry mouth and slower morning concentration during the first week. The symptoms improved after the regimen was adjusted, although he still avoided driving soon after taking a dose.

The first week 3 Nov 2026
Kevin B., 64 Verified
Rating: 3.5 out of 5

no city, had used clonidine for blood-pressure control for several months. He liked that his readings became less variable, but complained of constipation and occasional dizziness when getting out of bed. Drinking alcohol made the tiredness noticeably worse.

Several months 5 Oct 2026
Andrew, 46 Verified
Rating: 4.5 out of 5

no city, missed a dose during a busy workday and initially considered taking two tablets together. He followed the prescribed missed-dose plan instead and avoided a second dose close to the next one. His main complaint had been dry mouth rather than dizziness.

17 Oct 2026
Harry, 66 Verified
Rating: 4 out of 5

no city, reported good blood-pressure readings after titration but disliked the reduced alertness during the first fortnight. He said the treatment became more manageable after he stopped taking it immediately before tasks requiring concentration. He still needed a gradual withdrawal plan when the clinician changed therapy.

The first fortnight 10 Oct 2026
Get our free app Shop faster and track your orders 3.8 · 494 reviews Install